Jennifer Kelley

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

Alfonso Quintás‐Cardama, Kris Vaddi, Phillip Liu et al. · Blood · 2010 · 827 citations

Medicine, Hematology, Pharmacology +11

Absence of Post-translational Aspartyl β-Hydroxylation of Epidermal Growth Factor Domains in Mice Leads to Developmental Defects and an Increased Incidence of Intestinal Neoplasia

Joseph Dinchuk, Richard J. Focht, Jennifer Kelley et al. · Journal of Biological Chemistry · 2002 · 109 citations · Full text

Life Sciences, Developmental Biology, Genetics +13

INCB16562, a JAK1/2 Selective Inhibitor, Is Efficacious against Multiple Myeloma Cells and Reverses the Protective Effects of Cytokine and Stromal Cell Support

Jun Li, Margaret Favata, Jennifer Kelley et al. · Neoplasia · 2010 · 79 citations · Full text

Medicine, Oncology, Pharmacology +16

Intestinal Parasite Screening in Internationally Adopted Children: Importance of Multiple Stool Specimens

Mary Allen Staat, Marilyn Rice, Stephanie Donauer et al. · PEDIATRICS · 2011 · 57 citations · Full text

Medicine, Child Health, Pediatrics +17